Discover how recent Bayesian network meta-analyses map the long-term efficacy thresholds of amitriptyline vs botulinum toxin ...

Chronic pain might quietly push people toward developing high blood pressure—and the more widespread the pain, the greater the danger. A massive analysis of over 200,000 adults uncovered strong links ...

Over half of the people carrying HIV experience chronic pain at some point, which is difficult to treat. In a new JNeurosci ...

New pain psychotherapies, based on a new understanding of pain neuroscience, offer new possibilities of pain relief.

Real-world analysis of three years of closed claims data from Symphony Health, focused on the third year of the study (2023-2024), comprised of ...

Real-world analysis of three years of closed claims data from Symphony Health focused on the third year of the study (2023-2024), comprised of more than 261,000 U.S. adults with fibromyalgia Data unde ...

Real-world analysis of three years of closed claims data from Symphony Health focused on the third year of the study (2023-2024), comprised of more than 261,000 U.S. adults with fibromyalgia Data ...

Real-world analysis of three years of closed claims data from Symphony Health focused on the third year of the study (2023-2024), comprised of ...

Emergency doctors say they are grappling with a surge in a syndrome that can unexpectedly emerge in longtime marijuana users: cannabinoid hyperemesis syndrome.

With the FY 2026 ICD-10-CM guidelines officially active from October 1, 2025, medical coders face a new set of rules that demand precision to avoid costly claim denials. As AI tools increasingly ...

Quiver Bioscience ("Quiver"), a discovery platform, technology and therapeutics company advancing programs for the treatment of serious central nervous system (CNS) disorders and chronic pain, today ...